Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cardiac phenotype in familial partial lipodystrophy.

Clinical endocrinology - 1 Jun 2021

Eldin Abdelwahab Jalal, Akinci Baris, da Rocha Andre Monteiro, Meral Rasimcan, Simsir Ilgin Yildirim, Adiyaman Suleyman Cem, Ozpelit Ebru, Bhave Nicole, Gen Ramazan, Yurekli Banu, Ozdemir Kutbay Nilufer, Siklar Zeynep, Neidert Adam H, Hench Rita, Tayeh Marwan K, Innis Jeffrey W, Jalife Jose, Oral Hakan, Oral Elif A

Abstract excerpt

OBJECTIVES: LMNA variants have been previously associated with cardiac abnormalities independent of lipodystrophy. We aimed to assess cardiac impact of familial partial lipodystrophy (FPLD) to understand the role of laminopathy in cardiac manifestations. STUDY DESIGN: Retrospective cohort study. METHODS: Clinical data from 122 patients (age range: 13-77, 101 females) with FPLD were analysed. Mature human induced...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Induced Pluripotent Stem Cells

Share to Lamin Type A

Share to Lipodystrophy

Share to Lipodystrophy, Familial Partial

Share to Phenotype

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 33502018
DOI: 10.1111/cen.14426
PMCID: PMC9003538

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cardiac phenotype in familial partial lipodystrophy.PMID 33502018Read ↗

A recurrent familial partial lipodystrophy due to a monoallelic or biallelic LMNA founder variant highlights the multifaceted cardiac manifestations of metabolic laminopathies.Semantic proximity Read ↗

Updated clinical overview on cardiac laminopathies: an electrical and mechanical diseaseSemantic proximity Read ↗

Looking at New Unexpected Disease Targets in LMNA-Linked Lipodystrophies in the Light of Complex Cardiovascular Phenotypes: Implications for Clinical Practice.Semantic proximity Read ↗

Laminopathies: from the heart of the cell to the clinics.Semantic proximity Read ↗

Cardiovascular complications of lipodystrophic syndromes - focus on laminopathies.Semantic proximity Read ↗

Post-acute cardiac complications following SARS-CoV-2 infection in partial lipodystrophy due to LMNA gene p.R349W mutation.Semantic proximity Read ↗

Advances in lipodystrophy syndrome caused by LMNA gene mutation.Semantic proximity Read ↗

LMNA gene mutation as a model of cardiometabolic dysfunction: from genetic analysis to treatment response.Semantic proximity Read ↗

Investigating LMNA-Related Dilated Cardiomyopathy Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.Semantic proximity Read ↗

Case Report: Familial partial lipodystrophy, description of novel and ultrarare variants with distinct phenotypic spectrum.Semantic proximity Read ↗

Cardiomyopathy and sudden cardiac death as a rare presentation of mucolipidosis type III in a family with compound heterozygous variants in GNPTABSemantic proximity Read ↗

LMNA cardiomyopathy: cell biology and genetics meet clinical medicineSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.